# TELA Bio, Inc.: filings

TELA · Nasdaq · CIK 1561921 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tela.md) · [Financials](/companies/tela/financials.md) · [Filings](/companies/tela/filings.md) · [Insiders](/companies/tela/insiders.md)

## Reports and events: 151 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 234, 8-K 93, 3 31, 10-Q 21, SC 13G/A 14, SC 13D/A 13, SCHEDULE 13G/A 13, D 12, SC 13G 12, S-8 10, CORRESP 9, 424B5 8, DEF 14A 8, 10-K 7, DEFA14A 7, EFFECT 5, SCHEDULE 13G 5, UPLOAD 5, ARS 4, S-3 3, SC 13D 3, 144 2, 3/A 2, 424B4 2, 4/A 2, DRS 2, PRE 14A 2, S-1 2, S-1/A 2, SEC STAFF LETTER 2, 424B3 1, 8-A12B 1, 8-K/A 1, CERT 1, DEFR14A 1, DRS/A 1, DRSLTR 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-08 | 20:05 ET | [8-K](/filings/0001104659-26-114695.md) | 5.07 Shareholder vote results | 0001104659-26-114695 |
| 2026-10-06 | 20:05 ET | [8-K](/filings/0001104659-26-114042.md) | 8.01 Other events | 0001104659-26-114042 |
| 2026-10-05 | 12:05 ET | [8-K](/filings/0001104659-26-113506.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-113506 |
| 2026-09-29 | 20:05 ET | [8-K](/filings/0001104659-26-111920.md) | 1.01 Entry into a material agreement | 0001104659-26-111920 |
| 2026-09-18 | 20:05 ET | [8-K](/filings/0001104659-26-108935.md) | 3.01 Delisting notice | 0001104659-26-108935 |
| 2026-09-14 | 20:05 ET | [DEF 14A](/filings/0001104659-26-107491.md) | Proxy statement, period 2026-10-08 | 0001104659-26-107491 |
| 2026-08-31 | 11:05 ET | [8-K](/filings/0001104659-26-103548.md) | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-103548 |
| 2026-08-13 | 20:05 ET | [8-K/A](/filings/0001104659-26-095892.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-095892 |
| 2026-08-11 | 20:05 ET | [10-Q](/filings/0001104659-26-094039.md) | Quarterly report, period 2026-06-30 | 0001104659-26-094039 |
| 2026-08-10 | 20:12 ET | [8-K](/filings/0001104659-26-093371.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-093371 |
| 2026-08-04 | 11:08 ET | [8-K](/filings/0001104659-26-090056.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-090056 |
| 2026-06-11 | 20:05 ET | [8-K](/filings/0001104659-26-072931.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-072931 |
| 2026-06-09 | 22:29 ET | [SCHEDULE 13D](/filings/0001193125-26-264406.md) | Ownership report, active investor | 0001193125-26-264406 |
| 2026-05-13 | 20:06 ET | [10-Q](/filings/0001104659-26-060234.md) | Quarterly report, period 2026-03-31 | 0001104659-26-060234 |
| 2026-05-12 | 20:11 ET | [8-K](/filings/0001104659-26-059393.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-059393 |
| 2026-04-30 | 21:00 ET | [DEF 14A](/filings/0001104659-26-053117.md) | Proxy statement, period 2026-06-09 | 0001104659-26-053117 |
| 2026-04-30 | 20:57 ET | [8-K](/filings/0001104659-26-053102.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors | 0001104659-26-053102 |
| 2026-03-25 | 20:05 ET | [10-K](/filings/0001104659-26-034507.md) | Annual report, period 2025-12-31 | 0001104659-26-034507 |
| 2026-03-24 | 20:05 ET | [8-K](/filings/0001104659-26-033839.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-033839 |
| 2026-03-20 | 20:05 ET | [8-K](/filings/0001104659-26-032697.md) | 3.01 Delisting notice | 0001104659-26-032697 |
| 2025-11-14 | 21:38 ET | [8-K](/filings/0001104659-25-112653.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-25-112653 |
| 2025-11-14 | 21:06 ET | [10-Q](/filings/0001104659-25-112476.md) | Quarterly report, period 2025-09-30 | 0001104659-25-112476 |
| 2025-11-13 | 21:08 ET | [8-K](/filings/0001104659-25-111285.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-111285 |
| 2025-11-03 | 21:10 ET | [8-K](/filings/0001104659-25-105548.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-105548 |
| 2025-10-09 | 20:12 ET | [8-K](/filings/0001104659-25-098354.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-098354 |
| 2025-08-11 | 20:16 ET | [10-Q](/filings/0001558370-25-011052.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011052 |
| 2025-08-11 | 20:06 ET | [8-K](/filings/0001104659-25-076153.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-076153 |
| 2025-06-02 | 12:30 ET | [8-K](/filings/0001104659-25-055248.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-055248 |
| 2025-05-30 | 20:06 ET | [8-K](/filings/0001104659-25-054867.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001104659-25-054867 |
| 2025-05-08 | 20:30 ET | [10-Q](/filings/0001558370-25-006994.md) | Quarterly report, period 2025-03-31 | 0001558370-25-006994 |
| 2025-05-08 | 20:15 ET | [8-K](/filings/0001104659-25-046124.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-046124 |
| 2025-04-17 | 20:16 ET | [DEF 14A](/filings/0001104659-25-036020.md) | Proxy statement, period 2025-05-28 | 0001104659-25-036020 |
| 2025-03-31 | 11:15 ET | [8-K](/filings/0001104659-25-029612.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-029612 |
| 2025-03-21 | 20:05 ET | [10-K](/filings/0001558370-25-003460.md) | Annual report, period 2024-12-31 | 0001558370-25-003460 |
| 2025-03-20 | 20:15 ET | [8-K](/filings/0001104659-25-026142.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-026142 |
| 2024-11-08 | 21:05 ET | [10-Q](/filings/0001558370-24-015050.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015050 |
| 2024-11-07 | 21:15 ET | [8-K](/filings/0001104659-24-115317.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-115317 |
| 2024-10-25 | 20:24 ET | [SC 13D/A](/filings/0000947871-24-000823.md) | Ownership report, active investor, amended | 0000947871-24-000823 |
| 2024-10-23 | 21:16 ET | [8-K](/filings/0001104659-24-110891.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-110891 |
| 2024-10-22 | 20:01 ET | [8-K](/filings/0001104659-24-110552.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001104659-24-110552 |
| 2024-10-01 | 21:35 ET | [SC 13D/A](/filings/0000947871-24-000783.md) | Ownership report, active investor, amended | 0000947871-24-000783 |
| 2024-08-13 | 20:20 ET | [10-Q](/filings/0001558370-24-012060.md) | Quarterly report, period 2024-06-30 | 0001558370-24-012060 |
| 2024-08-12 | 20:15 ET | [8-K](/filings/0001104659-24-088353.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-088353 |
| 2024-07-02 | 20:58 ET | [SC 13D/A](/filings/0000947871-24-000584.md) | Ownership report, active investor, amended | 0000947871-24-000584 |
| 2024-06-06 | 20:15 ET | [8-K](/filings/0001104659-24-069099.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-069099 |
| 2024-05-20 | 20:15 ET | [8-K](/filings/0001104659-24-063416.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-063416 |
| 2024-05-10 | 20:05 ET | [10-Q](/filings/0001558370-24-007784.md) | Quarterly report, period 2024-03-31 | 0001558370-24-007784 |
| 2024-05-09 | 20:20 ET | [8-K](/filings/0001104659-24-059355.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-059355 |
| 2024-04-18 | 20:06 ET | [DEF 14A](/filings/0001104659-24-048835.md) | Proxy statement, period 2024-06-04 | 0001104659-24-048835 |
| 2024-04-15 | 11:13 ET | [8-K](/filings/0001104659-24-046970.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-046970 |

Page 1 of 4. [Older](/companies/tela/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.